Alterity Therapeutics Limited
ATH
Rangering i aksjer
#26212
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Aksjekurs
$0.18690047
Markedsverdi
$40.84M
Endring (1 dag)
3.92%
Endring (1 år)
-46.60%
Land
AU
Handel Alterity Therapeutics Limited (ATH)
Kategori
Healthcare
Historikk for aksjesplitt for Alterity Therapeutics Limited (ATH)
Aksjen Alterity Therapeutics Limited (symbol: ATH) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én ATH-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 ATH-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én ATH-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 ATH-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
